We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Digital screening for atrial fibrillation ready for prime time? Lessons learned from eBRAVE‐AF.
- Authors
Schreinlechner, Michael; Rizas, Konstantinos D.; Bauer, Axel
- Abstract
Atrial fibrillation (AF) is associated with significant morbidity and mortality that can be prevented by early detection and intervention.[1] Digital screening strategies offer an effective way to detect unknown AF and have the potential to be widely applicable to the general population. In eBRAVE-AF, increased age was not a negative factor, neither with regard to the quality or quantity of the PPG self-measurements nor with regard to the effectiveness of the digital AF screening. In conclusion, eBRAVE-AF was the first trial that could demonstrate the efficacy of digital screening to detect treatment-relevant AF directly compared to usual care.
- Subjects
MEDICAL screening; ATRIAL fibrillation
- Publication
Clinical & Translational Medicine, 2023, Vol 13, Issue 1, p1
- ISSN
2001-1326
- Publication type
Article
- DOI
10.1002/ctm2.1151